Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Journal of Oncology|November 7, 2022
The Prognostic Significance and Potential Mechanism of Prolyl 3-Hydroxylase 1 in Hepatocellular CarcinomaChunlei Li, Lilong Zhang, Yao Xu, et al.
Journal of Translational Medicine|February 16, 2023
Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinomaLilong Zhang, Chen Chen, Dongqi Chai, et al.
Frontiers in Immunology|September 5, 2022
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitorsLilong Zhang, Chen Chen, Dongqi Chai, et al.
Frontiers in Pharmacology|October 13, 2022
Effects of PPIs use on clinical outcomes of urothelial cancer patients receiving immune checkpoint inhibitor therapyLilong Zhang, Chen Chen, Dongqi Chai, et al.
International Journal of Biological Macromolecules|January 8, 2025
Functionalized covalent organic frameworks for catalytic conversion of biomass-derived xylan to furfuralYuan Ju, Kai Zhang, Peng Gan, et al.
Frontiers in Pharmacology|September 16, 2022
The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitorsLilong Zhang, Qi Jin, Dongqi Chai, et al.
The International Journal of Biochemistry & Cell Biology|November 29, 2011
TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cellsTao Wang, Lilong Zhang, Chunmeng Shi, et al.
BMC Cancer|January 31, 2023
The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancyLilong Zhang, Kailiang Zhao, Tianrui Kuang, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 22, 2023
High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancersRongqiang Liu, Zhendong Qiu, Lilong Zhang, et al.
Pageof 10